Page last updated: 2024-08-23

nafazatrom and quinacrine

nafazatrom has been researched along with quinacrine in 2 studies

*Quinacrine: An acridine derivative formerly widely used as an antimalarial but superseded by chloroquine in recent years. It has also been used as an anthelmintic and in the treatment of giardiasis and malignant effusions. It is used in cell biological experiments as an inhibitor of phospholipase A2. [MeSH]

*Quinacrine: An acridine derivative formerly widely used as an antimalarial but superseded by chloroquine in recent years. It has also been used as an anthelmintic and in the treatment of giardiasis and malignant effusions. It is used in cell biological experiments as an inhibitor of phospholipase A2. [MeSH]

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cannizzaro, S; Davì, G; Giubilato, A; Strano, A1
Bjøro, T; Englund, K; Haug, E; Torjesen, PA1

Reviews

1 review(s) available for nafazatrom and quinacrine

ArticleYear
[Platelet function inhibitors in peripheral arteriopathies].
    Recenti progressi in medicina, 1986, Volume: 77, Issue:4

    Topics: Adrenal Cortex Hormones; Adrenergic alpha-Antagonists; Anti-Inflammatory Agents; Arachidonic Acid; Arachidonic Acids; Arteriosclerosis Obliterans; Aspirin; Blood Platelets; Calcium Channel Blockers; Clinical Trials as Topic; Cyclic AMP; Dipyridamole; Extremities; Heparin; Humans; Imidazoles; Prostaglandins; Prostanoic Acids; Pyrazoles; Pyrazolones; Quinacrine; Thiophenes; Thromboembolism; Thrombosis; Ticlopidine; Vascular Diseases

1986

Trials

1 trial(s) available for nafazatrom and quinacrine

ArticleYear
[Platelet function inhibitors in peripheral arteriopathies].
    Recenti progressi in medicina, 1986, Volume: 77, Issue:4

    Topics: Adrenal Cortex Hormones; Adrenergic alpha-Antagonists; Anti-Inflammatory Agents; Arachidonic Acid; Arachidonic Acids; Arteriosclerosis Obliterans; Aspirin; Blood Platelets; Calcium Channel Blockers; Clinical Trials as Topic; Cyclic AMP; Dipyridamole; Extremities; Heparin; Humans; Imidazoles; Prostaglandins; Prostanoic Acids; Pyrazoles; Pyrazolones; Quinacrine; Thiophenes; Thromboembolism; Thrombosis; Ticlopidine; Vascular Diseases

1986

Other Studies

1 other study(ies) available for nafazatrom and quinacrine

ArticleYear
Inhibitors of the arachidonic acid metabolism attenuate the thyroliberin (TRH) stimulated prolactin production without modifying the production of inositolphosphates in GH4C1 pituitary cells.
    Scandinavian journal of clinical and laboratory investigation, 1993, Volume: 53, Issue:2

    Topics: 5,8,11,14-Eicosatetraynoic Acid; Animals; Arachidonic Acid; Inositol Phosphates; Lipoprotein Lipase; Lipoxygenase Inhibitors; Phospholipases A; Phospholipases A2; Pituitary Neoplasms; Prolactin; Pyrazoles; Pyrazolones; Quinacrine; Rats; Thyrotropin-Releasing Hormone; Tumor Cells, Cultured

1993